TIMP1 and neoplasm: If the former is true, the pro-tumor activity of TIMP-1 could be mediated through inhibition of activities of a subgroup of MMPs that may exert anti-tumor activity during late stages of tumor progression, which notion could offer an underlying reason for the failed clinical trials of the broad spectrum MMPIs that indiscriminately inhibit all MMP activities.